Top Stories BioXcel Stock Soars 19% After Hours Ahead of Key Trial Results UPDATE: BioXcel Therapeutics Inc. (BTAI) is making headlines as its stock skyrocketed 19.09% in after-hours trading, reaching $6.24 per share just hours before crucial... Editorial7 hours ago